Leukemia Research
Volume 24, Issue 12 , Pages 999-1008, December 2000

Dynamic cell cycle kinetics in vitro and in vivo in myelodysplastic syndromes with special reference to the influence of hematopoietic growth factors

  • Mette Holm

      Affiliations

    • Department of Hematology, Immunhæmatologisk Laboratorium, Århus amtssygehus, Tage-Hansens Gade 2, Opgang 4A, DK 8000 Århus, Denmark
    • Corresponding Author InformationCorresponding author. Tel.: +45-89497582; fax: +45-89497598
  • ,
  • Morten Høyer

      Affiliations

    • Department of Oncology, Onkologisk afdeling, Århus Kommunehospital, Nørrebrogade 44, DK 8000 Århus, Denmark
  • ,
  • Inger Jensen

      Affiliations

    • Department of Hematology, Immunhæmatologisk Laboratorium, Århus amtssygehus, Tage-Hansens Gade 2, Opgang 4A, DK 8000 Århus, Denmark
  • ,
  • Mette Thomsen

      Affiliations

    • Department of Hematology, Immunhæmatologisk Laboratorium, Århus amtssygehus, Tage-Hansens Gade 2, Opgang 4A, DK 8000 Århus, Denmark
  • ,
  • Peter Hokland

      Affiliations

    • Department of Hematology, Immunhæmatologisk Laboratorium, Århus amtssygehus, Tage-Hansens Gade 2, Opgang 4A, DK 8000 Århus, Denmark

Received 29 November 1999; accepted 10 June 2000.

Abstract 

We have investigated the effect of HGF in vivo and in vitro in MDS using a recently developed FCM assay involving the simultaneous measurement of cell surface antigens, DNA content, and BrdUrd or IodUrd incorporation. This allows for the determination of the dynamic cell kinetic parameters: LI, Ts, and Tpot and we observed that in vitro HGF stimulation resulted in a significant decrease in mean Tpot values from 6.6 to 3.5 days. Importantly, we demonstrated that in vivo GM-CSF administration to patients with RAEB resulted in a shortening of Tpot within the 2 first weeks of GM-CSF treatment.

Keywords:  Myelodysplastic syndromes, Cell cycle kinetics, Ts and Tpot, In vitro growth factor stimulation, GM-CSF administration, Heterogeneity

Abbreviations:  7-AAD, 7-amino-actinomycin D, AML, acute myeloid leukemia, BD, Becton Dickinson Immunocytometry Systems, BM, bone marrow, BP, band pass, BrdUrd, bromodeoxyuridine, BSA, bovine serum albumin, CM, complete medium, CT, chemotherapy, DMSO, dimethylsulfoxid, FAB, French–American–British, FCM, flow cytometric, FCS, fetal calf serum, G-CSF, granulocyte colony stimulating factor, GM-CSF, granulocyte/monocyte colony stimulating factor, Hgb, hemoglobin, HGF, hematopoietic growth factors, HSC, hematopoietic stem cells, IL, interleukin, IodUrd, iododeoxyuridine, IP, immunophenotyping, IPSS, International Prognostic Scoring System, LDA, leukocyte differentiation antigens, LI, labeling index, MDS, Myelodysplastic Syndromes, MNC, mononuclear cells, MoAb, monoclonal antibodies, NP, Nonidet P, PB, peripheral blood, PBS, phosphate-buffered saline, PFA, paraformaldehyde, PI, propidium iodide, RA, refractory anemia, RAEB, refractory anemia with excess blasts, RAEB-t, refractory anemia with excess blasts in transformation, RAS, refractory anemia with ring sideroblasts, SCF, stem cell factor, Tc, total cell cycle time, Tpot, potential doubling time, Ts, duration of the S-phase

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(00)00080-1

doi:10.1016/S0145-2126(00)00080-1

Leukemia Research
Volume 24, Issue 12 , Pages 999-1008, December 2000